Insulet Corp. (PODD) Analyst Ratings & Price Targets | Market Terminal

Market Terminal®

Market Terminal

Get Full Access To
Market Terminal — Try It For Free

Real-time breakouts. AI-powered analysis. The terminal that levels the playing field.

Open Terminal

BreakoutsScreenerAI AnalysisCalendarsMarketsNewsletters

Market Terminal®

Market Terminal

Get Full Access To
Market Terminal — Try It For Free

Real-time breakouts. AI-powered analysis. The terminal that levels the playing field.

Open Terminal

BreakoutsScreenerAI AnalysisCalendarsMarketsNewsletters

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.

Get Full Access To Market Terminal — Try It For Free

Get Full Access To Market Terminal — Try It For Free

Insulet Corp. (PODD)

Explore More Tools

Get Full Access To
Market Terminal — Try It For Free

Get Full Access To
Market Terminal — Try It For Free